Trials / Completed
CompletedNCT02441764
Halaven Post-Marketing Surveillance (PMS)
Post-Marketing Surveillance of Halaven Injection in Korean Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- Eisai Korea Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a PMS to observe the safety profile of Halaven in normal clinical practice setting.
Conditions
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2015-05-12
- Last updated
- 2020-03-10
Locations
12 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02441764. Inclusion in this directory is not an endorsement.